MSB 2022 - The road to commercialisation, page-21

@Cato is on the money with his comments and IMO
U miss the point.

Novartis is in a superior position to make informed judgements. Much more so than any poster on HC.

Novartis would not walk away from a promising medical treatment

And more importantly, they would not give up the opportunity and walk away from a chance to make a sh! t load of cash.

but they did.

If nothing else, it sends a very strong signal to would be investors, much more than any up ramping over optomistic blue sky HC poster, no matter how knowledgeable they think they are.

U.

As a shareholder, just want to make money, not fall in love with a stock